Skip to main content
Log in

Erhöhte zerebrale Erregbarkeit und "spreading depression"

Ursachen für eine Komorbidität von Epilepsie und Migräne?

  • Originalien
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

Zusammenfassung

Das gehäufte gemeinsame Auftreten und der Nachweis klinischer Gemeinsamkeiten von Epilepsie und Migräne werfen die Fragen nach einem gemeinsamen pathophysiologischen Modell der Erkrankungen auf. Jedoch fehlen bisher Hinweise für eine genetische Disposition der Komorbidität. Neuere klinische Studien bestätigen eine unspezifische Assoziation von Epilepsien und Migräne. Sie beruht am ehesten auf dem pathophysiologischen Mechanismus der "spreading depression" als ein Ausdruck für eine erhöhte zerebrale Erregbarkeit, die bei beiden Erkrankungen zu finden ist. Liegen beide Erkrankungen vor, bietet sich eine Migräneprophylaxe mit den Antikonvulsiva Valproinsäure, Gabapentin oder Topiramat an.

Summary

Increased co-occurrence and common clinical aspects of epilepsy and migraine lead to the question of a common pathophysiological model of the diseases. Shared genetic risk factors as an explanation for comorbidity could not be proven. Clinical studies underline the unspecific association of migraine and epilepsy. Comorbidity is based on spreading depression as an expression of altered brain state with neuronal hyperexcitability. In comorbid conditions, therapy with valproate, gabapentin, or topiramate may be effective.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1.
Abb. 2.
Abb. 3.
Abb. 4.
Abb. 5.

Literatur

  1. Afra J, Cecchini AP, De Pasqua V et al. (1998) Visual evoked potentials during long periods of pattern-reversal stimulation in migraine. Brain 121:233–241

    Article  PubMed  Google Scholar 

  2. Andermann F (2000) Migraine and the benign partial epilepsies of childhood: evidence for an association. Epileptic Disord 1:S37–39

    Google Scholar 

  3. Andermann E, Andermann F (1987) Migraine-epilepsy relationships: epidemiological and genetic aspects. In: Andermann F, Lugaresi E (eds) Migraine and epilepsy. Butterworths, Boston, pp 281–291

  4. Aurora SK, Cao Y, Bowyer SM, Welch KMA (1999) The occipital cortex is hyperexcitable in migraine: experimental evidence. Headache 39:469–476

    Article  CAS  PubMed  Google Scholar 

  5. Barolin GS(1966) Migraines and epilepsies—a relationship? Epilepsia 7:53–66

    Google Scholar 

  6. Bazil CW (1994) Migraine and epilepsy. Neurol Clin 12:115–128

    CAS  PubMed  Google Scholar 

  7. Bladin PF, Papworth G (1974) "Chuckling and gugging" seizures at night-sylvian spike epilepsy. Proc Australian Assoc Neurol 11:171–175

    CAS  Google Scholar 

  8. Camfield PR, Metrakos K, Andermann F (1978) Basilar migraine, seizures, and severe epileptiform abnormalities. Neurology 28:584–588

    Google Scholar 

  9. Cao Y, Welch KM, Aurora S, Vikingstad EM (1999) Functional MRI-BOLD of visually triggere headache in patients with migraine. Arch Neurol 56:548–554

    CAS  PubMed  Google Scholar 

  10. Carlsson A, Forsgren L, Nylander PO et al. (2002) Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1. Neurology 59:1804–1807

    CAS  PubMed  Google Scholar 

  11. De Romanis F, Buzzi MG, Cerbo R et al. (1991) Migraine and epilepsy with infantile onset and electroencephalogaphic findings of occipital spike-wave complexes. Headache 31:378–383

    PubMed  Google Scholar 

  12. Ferrari MD, Odnuk J, Bos KD et al. (1990) Neuroexcitatory plasma acids are elevated in migraine. Neurology 40:1582–1586

    CAS  PubMed  Google Scholar 

  13. Ferro JM, Melo TP, Oliveira V et al. (1995) A multivariate study of headache associated with ischemic stroke. Headache 35:315–319

    CAS  PubMed  Google Scholar 

  14. Fletcher CF, Lutz CM, o'Sullivan TN et al. (1996) Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87:607–617

    CAS  PubMed  Google Scholar 

  15. Förderreuther S, Henkel A, Noachtar S, Straube A (2002) Headache associated with epileptic seizures: epidemiology and clinical characteristics. Headache 42:649–655

    Article  PubMed  Google Scholar 

  16. Freitag FG, Collins SD, Carlson HA et al. (2002) A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 58:1652–1659

    CAS  PubMed  Google Scholar 

  17. Galeotti N, Ghelardini C, Zoppi M et al. (2001) Hypofunctionality of Gi proteins as aetiopathogenic mechanism for migraine and cluster headache. Cephalalgia 21:38–45

    CAS  PubMed  Google Scholar 

  18. Gorji A, Scheller D, Straub H et al. (2001) Spreading depression in human neocortical slices. Brain Res 906:74–83

    Article  CAS  PubMed  Google Scholar 

  19. Guipponi M, Rivier F, Vigevano F et al. (1997) Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. Hum Mol Genet 6:473–477

    Article  CAS  PubMed  Google Scholar 

  20. Hauser AW, Annegers JF, Anderson EV et al. (1993) The incidence of epilepsy and unprovoked seizures in Rochesta, Minnesota. Epilepsia 34:453–463

    CAS  PubMed  Google Scholar 

  21. Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 8 [Suppl 7]:1–96

  22. Hering R, Kuritzky A (1992) Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 12:81–84

    Article  CAS  PubMed  Google Scholar 

  23. Hirose S, Okada M, Kaneko S, Mitsudome A (2002) Molecular genetics of human familial epilepsy syndromes. Epilepsia 43 [Suppl 9]:21–25

  24. Jensen R, Brinck T, Olesen J (1994) Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-crossover study. Neurology 44:647–651

    CAS  PubMed  Google Scholar 

  25. Joutel A, Bousser MG, Biousse V et al. (1993) A gene for familial hemiplegic migraine maps to chromosome 19. Nature Genet 5:40–45

    CAS  PubMed  Google Scholar 

  26. Klapper J, on behalf of the Divalproex Sodium in Migraine Prophylaxis Study Group (1997) Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 17:103–108

    Article  CAS  PubMed  Google Scholar 

  27. Lampl C, Buzath A, Klinger D, Neumann K (1999) Lamotrigine in the prophylactic treatment of migraine aura- a pilot study. Cephalalgia 19:58–63

    Article  CAS  PubMed  Google Scholar 

  28. Lashley KS (1941) Patterns of cerebral integration indicated by scotomas of migraine. Arch Neurol Psychiatry 46:331–339

    Google Scholar 

  29. Lauritzen M (1994) Pathophysiology of the migraine aura. The spreading depression theory. Brain 118:199–210

    Google Scholar 

  30. Leao AAP (1944) Spreading depression of activity in the cerebral cortex. J Neurophysiol 7:359–390

    Google Scholar 

  31. Leniger T, Diener HC (1999) Migräne und Epilepsie—ein Zusammenhang? Akt Neurol 26:116–120

    Google Scholar 

  32. Leniger T, Diener HC (2000) Die Antikonvulsiva Valproinsäure, Gabapentin, Topiramat und Lamotrigin in der Migränetherapie. Akt Neurol 27:475–479

    Google Scholar 

  33. Leniger T, Isbruch K, von den Driesch S et al. (2001) Seizure-associated headache in epilepsy. Epilepsia 42:1176–1179

    Article  CAS  PubMed  Google Scholar 

  34. Leniger T, von den Driesch S, Isbruch K et al. (2003) Clinical characteristics of patients with comorbidity of migraine and epilepsy. Headache 43:672–677

    Google Scholar 

  35. Leppert M, Anderson VE, Quattlebaum T et al. (1989) Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 337:647–648

    CAS  PubMed  Google Scholar 

  36. Lewis TB, Leach RJ, Ward K et al. (1993) Genetic heterogeneity in benign familial neonatal convulsions: identification of a new locus on chromosome 8q. Am J Hum Genet 53:670–675

    CAS  PubMed  Google Scholar 

  37. Lipton RB, Ottman R (1994) Comorbidity of migraine: the connection between migraine and epilepsy. Neurology 44:28–32

    PubMed  Google Scholar 

  38. Marks DA, Ehrenberg BL (1993) Migraine-related seizures in adults with epilepsy, with EEG correlation. Neurology 43:2476–2483

    CAS  PubMed  Google Scholar 

  39. Martinovic Z, Cvorovic Z (1999) Migraine epilepsy syndromes: their evolution and treatment. Abstract. Cephalalgia 19:333

    Google Scholar 

  40. Mathew NT, Kailasam J, Meadors L (2002) Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache 42:796–803

    Article  PubMed  Google Scholar 

  41. Mathew NT, Saper JR, Silberstein SD et al. (1995) Migraine prophylaxis with divalproex. Arch Neurol 52:281–286

    CAS  PubMed  Google Scholar 

  42. Mathew NT, Rapoport A, Saper J et al. (2001) Efficacy of gabapentin in migraine prophylaxis. Headache 41:119–128

    Article  CAS  PubMed  Google Scholar 

  43. Mulleners WM, Chronicle EP, Palmer JE et al. (2001) Visual cortex excitability in migraine with and without aura. Headache 41:565–572

    CAS  PubMed  Google Scholar 

  44. Niedermeyer E (1993) Migraine-triggered epilepsy. Clin Electroencephalogr 24:37–43

    Google Scholar 

  45. Noble-Topham SE, Dyment DA, Cader MZ et al. (2002) Migraine with aura is not linked to the FHM gene CACNA1A or the chromosomal region, 19p13. Neurology 59:1099–1101

    CAS  PubMed  Google Scholar 

  46. Ophoff RA, Terwindt GM, Vergouwe MN et al. (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87:543–552

    CAS  PubMed  Google Scholar 

  47. Ottmann R, Lipton RB (1994) Comorbidity of migraine and epilepsy. Neurology 44:2105–2110

    PubMed  Google Scholar 

  48. Pryse Phillips W, Findlay H, Tugwell P et al. (1992) A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci 19:333–339

    PubMed  Google Scholar 

  49. Rasmussen BK (1995) Epidemiology of headache. Cephalalgia 15:44–45

    Article  PubMed  Google Scholar 

  50. Rasmussen BK, Jensen R, Schroll M, Olesen J (1991) Epidemiology of headache in a general population—a prevalence study. J Clin Epidemiol 44:1147–1157

    CAS  PubMed  Google Scholar 

  51. Russell MB (2001) Genetics of migraine without aura, migraine with aura, migrainous disorder, head trauma migraine without aura and tension-type headache. Cephalalgia 21:778–780

    Article  CAS  PubMed  Google Scholar 

  52. Schoenen J (1998) Cortical electrophysiology in migraine an dpossible pathogenetic implications. Clion Neurosci 5:10–17

    CAS  Google Scholar 

  53. Steiner TJ, Findley LJ, Yuen AWC (1997) Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17:109–112

    Article  CAS  PubMed  Google Scholar 

  54. Terwindt GM, Ophoff RA, Lindhout D et al. (1997) Partial cosegregation of familial hemiplegic migraine and a benign familial infantil epileptic syndrome. Epilepsia 38:915–921

    CAS  PubMed  Google Scholar 

  55. Von Seggern RL, Mannix LK, Adelman JU (2002) Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysis. Headache 42:804–809

    Article  PubMed  Google Scholar 

  56. Welch KMA, Lewis D (1997) Migraine and epilepsy. Adv Headache 15:107–114

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Leniger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leniger, T., Diener, H.C. & Hufnagel, A. Erhöhte zerebrale Erregbarkeit und "spreading depression". Nervenarzt 74, 869–874 (2003). https://doi.org/10.1007/s00115-003-1538-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-003-1538-x

Schlüsselwörter

Keywords

Navigation